Laddar...
Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer
Human epidermal growth factor receptor 2 (HER2) protein overexpression or gene amplification is an important predictive biomarker for identifying patients with breast cancer, who may benefit from HER2-targeted therapy. However, little is known about the molecular landscape and efficacy of HER2-targe...
Sparad:
| I publikationen: | NPJ Breast Cancer |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7603305/ https://ncbi.nlm.nih.gov/pubmed/33145402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-020-00201-9 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|